You just read:

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial; MiStent Achieved Primary Endpoint vs Xience®

News provided by

Micell Technologies

Dec 06, 2017, 11:25 EST